HomeREDX • LON
add
Redx Pharma PLC
Previous close
GBX 9.25
Year range
GBX 4.00 - GBX 37.90
Market cap
35.60M GBP
Avg Volume
1.27M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
(GBP) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 945.50K | -81.71% |
Operating expense | 7.63M | -22.38% |
Net income | -6.20M | -50.33% |
Net profit margin | -655.21 | -721.79% |
Earnings per share | — | — |
EBITDA | -6.45M | -45.48% |
Effective tax rate | -2.05% | — |
Balance Sheet
Total assets
Total liabilities
(GBP) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 18.09M | -66.41% |
Total assets | 25.64M | -58.97% |
Total liabilities | 22.28M | -23.58% |
Total equity | 3.36M | — |
Shares outstanding | 334.91M | — |
Price to book | 9.25 | — |
Return on assets | -65.15% | — |
Return on capital | -79.40% | — |
Cash Flow
Net change in cash
(GBP) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -6.20M | -50.33% |
Cash from operations | -8.04M | -45.40% |
Cash from investing | -15.50K | 62.65% |
Cash from financing | -204.00K | -101.22% |
Net change in cash | -8.26M | -174.17% |
Free cash flow | -3.83M | -109.31% |
About
CEO
Founded
2010
Website
Employees
101